Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison (Q33528162)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison |
scientific article |
Statements
1 reference
Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison (English)
1 reference
Giuseppe Viale
1 reference
Filippo Montemurro
1 reference
Stefania Redana
1 reference
Michela Donadio
1 reference
Franco Nolè
1 reference
Maria Elena Jacomuzzi
1 reference
Alessandra Beano
1 reference
Rossella Martinello
1 reference
1 February 2010
1 reference
1 reference
10
1 reference
28
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference